|
|
||||||||
a Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University, Lazarettstr. 36, D-80636 Munich, Germany
b Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich at the Technical University, Munich, Germany
Received 24 July 2007; received in revised form 13 November 2007; accepted 20 November 2007.
* Corresponding author. Tel.: +49 89 1218 4111; fax: +49 89 1218 4123. (Email: hoerer{at}dhm.mhn.de).
| Abstract |
|---|
|
|
|---|
Key Words: Congenital heart disease Transposition of great arteries Adults
| 1. Introduction |
|---|
|
|
|---|
Survival was reported to range between 75% and 90% 25 years after the Mustard operation [3] and 25 years after the Senning operation [4], respectively. However, atrial switch procedures are associated with reoperations mainly for systemic ventricular dysfunction and baffle complications. Besides heart transplantation and tricuspid valve surgery, the conversion to ASO was considered to handle those patients with failing right ventricles. In most cases, these procedures are performed once the right ventricular function has already deteriorated, and left ventricular training may no longer be possible, with the consequence of a high operative mortality [6–9]. A mortality rate of up to 42% has also been reported with respect to baffle reoperations [10]. Hence, reoperations are a challenge in this adult patient population with complex anatomy and account for a significant number of late deaths.
The aim of the present study was to identify the incidence, indication, and the outcome of reoperations in a population of 314 hospital survivors after the Senning operation.
| 2. Patients and methods |
|---|
|
|
|---|
2.2 Study group
The cohort included 219 male and 95 female patients who had undergone the Senning operation between 1977 and 2001. A simple TGA was diagnosed in 217 patients (69.1%), a TGA + VSD (ventricular septal defect) in 63 patients (20.1%), a TGA + LVOTO (left ventricular outflow tract obstruction) in 15 patients (4.8%), and a TGA + VSD + LVOTO in 19 patients (6.1%).
2.3 Surgical technique
The operation was performed as described by Senning [1]. VSD-closure was performed in 55 patients. The VSD was closed via a right atrial approach in all but one patient, in which it was closed through the ascending aorta. VSD-closure was performed with a patch in 32 patients, and by direct suture in 23 patients. Details concerning the operative technique are reported elsewhere [4].
2.4 Data collection and follow-up
Preoperative, perioperative, and follow-up data were retrospectively reviewed for details concerning cardiac reoperations. The prospective arm of the study consisted of a written questionnaire that was sent to all patients between May 2003 and July 2004. Fifteen patients were lost to follow-up at a mean time of 11.3 ± 7.6 years after the Senning operation (follow-up 94.8% complete). Mean follow-up time was 18.2 ± 5.7 years (maximum 27 years). The functional status was determined according to the New York Heart Association (NYHA) functional class, and the ability index, as described by Warnes and Somerville [11]. In case of death, the relatives and the general physicians of the patients were contacted to determine the cause of death.
2.5 Data analysis
Descriptive data for continuous variables are presented as means ± standard deviation; categorical variables are presented as relative frequencies. The outcome parameters were defined as time from the Senning operation to death, and time to reoperation for baffle complications, right ventricular dysfunction, or left ventricular outflow tract obstruction. Reoperation for baffle complications was defined as operation including enlargement of the venous pathways, and/or closure of baffle leaks, excluding any other concomitant procedure. Reoperation for systemic ventricular failure was defined as any operation including one or more of the following procedures: tricuspid valve repair or replacement, pulmonary artery banding (PAB), and ASO including Senning take-down. Reoperation for left ventricular outflow tract obstruction was defined as any operation including conduit placement from the left ventricle to the pulmonary artery or enlargement of the left ventricular outflow tract, including any other procedures except procedures performed for right ventricular dysfunction. The probability of freedom from events was estimated according to the Kaplan–Meier method. Freedom-from-event curves were compared using the log-rank test. P values <0.05 were considered as significant. Analyses were performed with SPSS 14.0.2 for Windows (SPSS Inc., Chicago, IL).
| 3. Results |
|---|
|
|
|---|
|
|
|
Of the 30 patients who survived the first reoperation, 4 patients died during a mean follow-up time of 7.7 ± 5.9 years after the first reoperation. Three patients died after reoperation for systemic ventricular failure. One 2-year-old patient died from an unknown cause 4 months after reoperation for tricuspid valve repair. One 17-year-old patient died from right heart failure 16 months after reoperation for tricuspid valve repair, PAB and enlargement of the venous pathways. As mentioned above, one patient died 23 months after PAB, enlargement of the left ventricular outflow tract and the venous pathways during the second reoperation for ASO and Senning take-down. There was one death after reoperation for baffle leak. This patient died 9 years after the reoperation from right heart failure and pulmonary hypertension at the age of 16 years. There was no late death after reoperation for left ventricular outflow tract obstruction.
Survival after reoperation for systemic ventricular failure at 30 days, 1 year, and 5 years was 91.7 ± 8.0%, 83.3 ± 10.8%, and 64.8 ± 14.3%, respectively. Survival after reoperation for baffle complication and left ventricular outflow tract obstruction at 5 years was 85.7 ± 13.2% and 83.3 ± 15.2%, respectively (Fig. 3 ).
|
Data concerning the functional status of patients who underwent reoperations could be obtained from 6 patients after a mean time interval of 6.5 ± 2.5 years after reoperation for systemic ventricular dysfunction, from 10 patients after a mean time interval of 11.4 ± 6.9 years after reoperation for baffle complications, and from 6 patients after a mean time interval of 10.7 ± 2.7 years after reoperation for LVOTO. The proportion of patients assigned to NYHA functional class I was lower in patients following reoperations compared to patients, who did not undergo reoperations (Fig. 4 ).
|
| 4. Discussion |
|---|
|
|
|---|
Baffle stenoses or baffle leaks account for most of the reoperations in previously reported series. In the Toronto Mustard group, 5% of 478 hospital survivors underwent reoperations of baffle complications during a mean follow-up period of 11.6 ± 7.2 years [10]. A lower rate of baffle reoperations was reported by Oechslin and Jenni from the Zurich Senning group. During a mean follow-up period of 13.4 years, 3% of hospital survivors underwent baffle reoperations [3]. A lower rate of baffle reoperations in Senning patients compared to Mustard patients was also reported by Sarkar et al. [15]. In their study, the reoperation rate for baffle complications was 12% in 226 hospital survivors after the Mustard operation, and 2% in 132 hospital survivors after the Senning operation, with mean follow-up intervals of 11.7 ± 6.1 years and 13.4 ± 6.5 years, respectively. In the present Senning group, we observed a reoperation rate for baffle complications of 5.4% during a mean follow-up period of 18.2 ± 5.7 years, which was also significantly lower compared to the Mustard series of our institution [4]. Interestingly, freedom from baffle reoperation curves suggests that there is an ongoing risk for baffle complications in adulthood.
The relief of stenoses of the venous pathways is of major importance because due to impaired filling of the ventricle, baffle stenoses may contribute to severe low cardiac output and to sudden death in case of ventricular tachycardia. Sudden death was reported to be higher in patients who had undergone a Mustard operation compared to patients who had undergone a Senning operation [3,4]. This may be due to the lack of flexibility of the synthetic material that is used to create the venous pathways in the Mustard procedure. In contrast, the Senning procedure uses autologous tissue for baffle construction. Surgical relief of baffle stenoses has proven to be efficacious in the present study population. There was no second reoperation for baffle stenoses necessary during a mean follow-up time of 11.2 ± 6.6 years after the first reoperation for baffle complications. Relief of venous pathway obstructions by gradual angioplasty and placement of stents was reported to be an alternative approach for the treatment of baffle obstructions [16,17]. However, careful long-term follow-up of transcatheter treatment of channel obstructions is mandatory.
A mortality rate of up to 42% has been reported to be associated with reoperations for baffle complications [10]. In contrast, there was no death during reoperations for exclusively baffle revision in the present study population. Survival after the Senning operation for patients who underwent exclusively baffle reoperations was similar compared to patients who did not undergo reoperations. This indicates that reoperations for baffle revision can be performed with low operative mortality and good results in the long-term, at least in patients with preserved systemic ventricular function and competent tricuspid valve.
Reoperations for systemic ventricular dysfunction account for the second most frequent indication for reoperations in the present study population. In the literature, the incidences of reoperations for systemic ventricular failure were reported to range between 1% and 2% [3,15,18]. In the present cohort with the longest reported follow-up interval to date, 3.8% of the patients underwent reoperations for systemic ventricular failure. The surgical strategies applied to those patients need to take the function of the ventricles, the function of the valves, the presence of associated lesions such as LVOTO, the cardiac rhythm, and finally the age of the patient into account.
Tricuspid insufficiency may be the result of annular dilatation as a consequence of right ventricular dysfunction or the consequence of iatrogenic damage of the tricuspid valve during transtricuspid VSD-closure at the time of the initial operation. In the present study group, the incidence of reoperations for tricuspid valve repair was not significantly higher in patients who had undergone transtricuspid VSD-closure indicating that right ventricular dilatation may be the main cause for the development of an insufficiency of the systemic atrioventricular valve. In addition, three of the five patients who underwent tricuspid valve repair in the present study group did not present with a VSD at the time of the Senning operation. Hence, the outcome after tricuspid valve repair in patients with right ventricular dysfunction is poor, since the ventricular dysfunction remains untreated. Wells and Blackstone reported on a Mustard patient presenting with right ventricular failure who did not survive reoperation for tricuspid valve replacement [10]. In the present cohort, tricuspid valve repair failed in two patients presenting with severe right ventricular dysfunction. One patient died 4 months after surgery, the other patient exhibited severe tricuspid insufficiency and right ventricular dysfunction 4 years after reoperation. In contrast, one patient with tricuspid insufficiency and preserved right ventricular dysfunction presented with mild tricuspid insufficiency and mildly impaired right ventricular function at final follow-up. From their experiences with patients presenting with congenitally corrected transposition of the great arteries and tricuspid insufficiency, Acar et al. reported that tricuspid valve repair always failed when the right ventricle is left in the systemic position [19]. This might also be the case in patients who had undergone an atrial switch operation suggesting that a strategy of conversion to ASO may be beneficial in patients presenting with tricuspid insufficiency.
Poirier and Mee [20] reported an improvement of tricuspid regurgitation and functional status after PAB in patients with systemic right ventricle. This finding was confirmed by Winlaw et al. [21] who also found improvement in functional status after PAB. However, in contrast to Poirier and colleagues, this was not mirrored by an improvement in tricuspid regurgitation. In our cohort, of four patients who received PAB, and who did not undergo ASO, three are in ability index class I after a mean time of 7.2 ± 1.0 years after the PAB. One patient died 1.4 years after PAB from heart failure. Like Winlaw et al. [21] we could observe functional improvement without improvement in tricuspid regurgitation. However, these findings suggest that PAB as definitive palliation may be a valid option for these patients if one takes into account the high operative mortality of a conversion by an ASO.
The hospital mortality of an ASO and atrial switch take-down ranges from 13% to 33% in the literature [6–8]. In addition, there is a significant interim mortality between PAB and conversion. In the present cohort, overall mortality of this approach was 33% with one patient dying after PAB and two patients dying at the time of conversion. The response to PAB is very fast in children [22], and the likelihood of successful conversion to ASO after PAB is higher in patients younger than 16 years of age [21]. However, since most of the patients of the present cohort are now grown-up and PAB for left ventricular reconditioning may lead to rapid left ventricular failure in adult patients [9], this strategy will no longer be a therapeutic option for these patients. In this study, PAB or ASO without prior banding was exclusively performed in patients below the age of 16 years. Finally, the fate of the systemic left ventricle and the neoaortic valve in patients who underwent successful conversion by an ASO is unknown [15]. In the present cohort, two patients had undergone aortic valve replacement following ASO. Presumably, heart transplantation will be the only surgical option for these patients with failing right ventricle. Fortunately, among adults with congenital heart disease who undergo cardiac transplantation, those who had undergone an atrial switch operation seem to do well [23].
Surprisingly, the third main cause for reoperations in the present population was left ventricular outflow tract obstruction, which has not been reported previously in other patient groups who had undergone an atrial switch operation. Presumably, the Senning operation was preferred to the Rastelli operation in patients with TGA, VSD, and mild pulmonary stenosis to avoid conduit implantation prior to the era of ASO. The long-term outcome of these patients seems to justify this approach. Survival of 34 hospital survivors presenting with TGA, VSD, and pulmonary stenosis 20 years after the Senning operation was 90.2 ± 4.5%, compared to 57.5 ± 15.1% of 39 hospital survivors 20 years after the Rastelli operation at our institution [24].
Loss of sinus rhythm at long-term has been described in patients after atrial baffle procedures [18,25]. Freedom from pacemaker insertion in the present Senning group was 98.7% at 10 years, and thus compares favorably to the findings by Wells and Blackstone [10] (91% at 10 years). At 20 years, freedom from pacemaker insertion was still 94.4%. However, at 25 years, freedom from pacemaker insertion decreased to 81.3%, indicating that loss of sinus rhythm might become a serious problem in this special entity of patients in the near future.
In conclusion, reoperations following the Senning operation are rare. Reoperations for baffle complications or left ventricular outflow tract obstruction can be performed with low operative mortality and good results in the mid-term in patients with preserved systemic ventricular function. However, the results of tricuspid valve repair are not encouraging in patients presenting with systemic ventricular dysfunction. Conversion by an ASO and restoring the left ventricle into the systemic position will no longer be an option since most of the patients will not respond to PAB because of advanced age. Hence, PAB without the intention to achieve systemic pressure for conversion as definitive palliation or as bridge to transplant may be the way for those patients.
| Appendix A |
|---|
|
|
|---|
Dr J. Stark (London, United Kingdom): In the options for the right ventricular failure, you didnt include transplantation in your original slide. Is it because you have not performed any transplantations, or in view of the last slide, you would consider it as an option now?
Dr Hörer: Yes, that is correct, there was no heart transplantation in this Senning group. We did one cardiac transplantation in a group of 88 Mustard patients, but in the Senning group there was no transplantation.
Dr Stark: Until what age would you consider conversion to arterial switch?
Dr Hörer: This is a difficult question. I dont think that it's just a matter of age. We consider the conversion under the age of 16, but all of our patients now are older than 16. The mean age of the Senning patients now is 20. That's why I concluded that this will probably no longer be an option for those patients.
Dr Stark: Because it is also in the literature, certainly from Dr Mee, that the results over 16 are poor, so probably transplantation would be a better option.
Dr Hörer: Yes. It would be the same cut-off point as for patients with congenitally corrected transposition who are scheduled for a double switch procedure.
Dr R. Pretre (Zurich, Switzerland): You also had some patients in your cohort with LVOT obstruction who might have a trained left ventricle without any banding. Would you consider an anatomical correction then?
Dr Hörer: In principle, yes, they are ideal candidates if they have systemic pressure in the left ventricle and at the same time low pressure in the pulmonary artery.
| Footnotes |
|---|
Presented at the 21st Annual Meeting of the European Association for Cardio-thoracic Surgery, Geneva, Switzerland, September 16–19, 2007. | References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. Sareyyupoglu, H. M. Burkhart, D. J. Hagler, J. A. Dearani, A. Cabalka, F. Cetta, and H. V. Schaff Hybrid approach to repair of pulmonary venous baffle obstruction after atrial switch operation. Ann. Thorac. Surg., November 1, 2009; 88(5): 1710 - 1711. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Turina Editorial comment Eur. J. Cardiothorac. Surg., June 1, 2008; 33(6): 1067 - 1068. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |